SCHEMBL166674

SCHEMBL166674

CCCOC(=O)CCC(C)=O

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.50
ADRA2A P08913 1/20 0.48
ADRA1A P35348 1/20 0.48
ALDH1A1 P00352 7/20 0.48
MAPT P10636 4/20 0.46
BLM P54132 1/20 0.46
HTR2C P28335 1/20 0.44
DNM1 Q05193 1/20 0.41
LMNA P02545 2/20 0.40
NAAA Q02083 1/20 0.40
SLC15A2 Q16348 1/20 0.40
HCAR2 Q8TDS4 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
MAPK1 P28482 1/20 0.38
GLA P06280 1/20 0.38
TOP2A P11388 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propanol SCHEMBL811005 0.94 DGKA (0.45) DGKAADRA2AADRA1AALDH1A1MAPT
Hexane SCHEMBL1882910 0.94 DGKA (0.61) DGKAADRA2AADRA1AALDH1A1MAPT
SCHEMBL20589 0.90 DGKA (0.58) DGKAADRA2AADRA1AALDH1A1MAPT
Acetic Acid SCHEMBL28208274 0.88 DGKA (0.52) DGKAADRA2AADRA1AALDH1A1MAPT
SCHEMBL13635974 0.87 ALDH1A1 (0.56) DGKAADRA2AADRA1AALDH1A1MAPT
SCHEMBL16020428 0.87 DGKA (0.48) DGKAADRA2AADRA1AALDH1A1MAPT
SCHEMBL118152 0.86 ALDH1A1 (0.58) DGKAADRA2AADRA1AALDH1A1MAPT
SCHEMBL14447420 0.86 DGKA (0.57) DGKAADRA2AADRA1AALDH1A1MAPT
SCHEMBL14573478 0.85 ALDH1A1 (0.53) DGKAADRA2AADRA1AALDH1A1MAPT
Methyl Alcohol SCHEMBL7132015 0.85 ALDH1A1 (0.56) DGKAADRA2AADRA1AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661299-A Method for synthesizing cyclopentadiene from levulinic acid and derivative thereof 中国科学院大连化学物理研究所 2025-03-21 CN claimed
CN-118006576-B Amine dehydrogenase mutant and method for synthesizing non-alpha-amino acid 江南大学 2025-02-14 CN claimed
US-20250040543-A1 Preservative Composition Arxada Switzerland AG (CH) 2025-02-06 US claimed
CN-116265471-B Method for preparing 1, 4-anhydroerythritol ketal compound 中国科学院大连化学物理研究所 2025-01-24 CN claimed
CN-119346184-A Rubber sludge-based catalytic transfer hydrogenation catalyst and preparation method and application thereof 昆明理工大学 2025-01-24 CN claimed
US-20250002444-A1 PROCESS FOR FORMING ALKYL ESTER OF LEVULINIC ACID BASF SE (DE) 2025-01-02 US claimed
CN-119080615-A Method for preparing long-chain dibasic acid or dibasic ester 中国科学院大连化学物理研究所 2024-12-06 CN claimed
CN-118950036-A Modified biomass catalyst and preparation method and application thereof 鲁东大学 2024-11-15 CN claimed
US-20240360312-A1 PURIFICATION METHODS FOR MODIFIED ROSIN COMPOSITIONS MAINSTREAM PINE PRODUCTS, LLC 2024-10-31 US claimed
CN-118634813-A Mn-based catalyst and application thereof in catalytic conversion of levulinic acid and derivatives thereof 南昌大学 2024-09-13 CN claimed
EP-1907514-A1 FUEL COMPOSITIONS Shell Internationale Research Maatschappij B.V. (NL) 2008-04-09 EP claimed
EP-1907513-A1 FUEL COMPOSITIONS Shell Internationale Research Maatschappij B.V. (NL) 2008-04-09 EP claimed
US-20070175090-A1 Fuel compositions SHELL OIL COMPANY 2007-08-02 US claimed
US-20070094919-A1 Fuel compositions SHELL OIL COMPANY 2007-05-03 US claimed
WO-2007012585-A1 FUEL COMPOSITIONS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2007-02-01 WO claimed
WO-2007012586-A1 FUEL COMPOSITIONS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2007-02-01 WO claimed
EP-0839541-B1 Coating mixture for surgical articles ETHICON INC (US) 2004-05-06 EP claimed
US-5786022-A BLEND OF BIOCOMPATABLE POLYMER AND SOLVENT ETHICON, INC. (US) 1998-07-28 US claimed
EP-0839541-A2 Coating mixture for surgical articles Ethicon, Inc. (US) 1998-05-06 EP claimed
US-4153064-A Cigarette filters DAICEL LTD. (JP) 1979-05-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250040543-A1 Preservative Composition PHOSPHO1, PSEN1, PSEN2 DGKA 2847/4885ADRA2A 2725/4885ADRA1A 2345/4885
US-20250002444-A1 PROCESS FOR FORMING ALKYL ESTER OF LEVULINIC ACID GABRG1, GABRE, ALAD DGKA 2886/4885ADRA2A 3180/4885ADRA1A 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.